2,553 followers
RT @HealthEconBot: #HealthEconJA Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respira…
RT @HealthEconBot: #HealthEconJA Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respira…
#HealthEconJA Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach https://t.co/XWoXe2Ex9A